Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 MillionStandby Equity Purchase Agreement • April 24th, 2025
Contract Type FiledApril 24th, 2025Under the terms of the agreement, Yorkville has committed to purchasing up to EUR 15 million of ordinary shares of Vivoryon over the course of 36 months, from the date of signing the agreement. Vivoryon has the right, but not the obligation, to sell these ordinary shares to Yorkville in individual tranches under exclusion of the existing shareholders’ pre-emptive rights.